Absorption of dimethoxycinnamic acid derivatives in vitro and pharmacokinetic profile in human plasma following coffee consumption

Molecular Nutrition and Food Research

Volumn 56, Issue 9, 2012, Pages 1413-1423

  Farrell, Tracy L ^a   Gomez Juaristi, Miren ^b   Poquet, Laure ^c   Redeuil, Karine ^c   Nagy, Kornél ^c   Renouf, Mathieu ^c   Williamson, Gary ^c  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b INSTITUTE OF FOOD SCIENCE   (Spain)

^c NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Bioavailability; Caco 2 cells; Coffee; Human plasma; Phenolic acids

Indexed keywords

3 (3,4 DIMETHOXYPHENYL)PROPENOIC ACID; 3-(3,4-DIMETHOXYPHENYL)PROPENOIC ACID; CINNAMIC ACID DERIVATIVE; POLYPHENOL;

ABSORPTION; ADULT; ARTICLE; BLOOD; CELL STRAIN CACO 2; COFFEE; DIET; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY;

ABSORPTION; ADULT; CACO-2 CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CINNAMATES; COFFEE; DIET; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; POLYPHENOLS; YOUNG ADULT;

EID: 84865726906     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200021     Document Type: Article

References (30)

1. Clifford, M. N., Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. J. Sci. Food Agric. 1999, 79, 362-372.
2. n of four new classes of chlorogenic acids in green coffee beans: dimethoxycinnamoylquinic acids, diferuloylquinic acids, caffeoyl-dimethoxycinnamoylquinic acids, and feruloyl-dimethoxycinnamoylquinic acids. J. Agric. Food Chem. 2006, 54, 1957-1969.
3. Alonso-Salces, R. M., Serra, F., Reniero, F., Heberger, K., Botanical and geographical characterization of green coffee (Coffea arabica and Coffea canephora): chemometric evaluation of phenolic and methylxanthine contents. J. Agric. Food Chem. 2009, 57, 4224-4235.
4. Huxley, R., Lee, C. M. Y., Barzi, F., Timmermeister, L. et al., Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus a systematic review with meta-analysis. Arch. Intern. Med. 2009, 169, 2053-2063.
5. Je, Y. J., Liu, W., Giovannucci, E., Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int. J. Cancer. 2009, 124, 1662-1668.
6. Galeone, C., Turati, F., La Vecchia, C., Tavani, A., Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control studies. Cancer Cause Control 2010, 21, 1949-1959.
7. Kempf, K., Herder, C., Erlund, I., Kolb, H. S. et al., Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am. J. Clin. Nutr. 2010, 91, 950-957.
8. Rocha, B. S., Gago, B., Barbosa, R. M., Laranjinha, J., Dietary polyphenols generate nitric oxide from nitrite in the stomach and induce smooth muscle relaxation. Toxicology 2009, 265, 41-48.
9. Shan, J. H., Fu, J., Zhao, Z. H., Kong, X. Q. et al., Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-kappa B and JNK/AP-1 activation. Int. Immunopharmacol. 2009, 9, 1042-1048.
10. Bergmann, H., Rogoll, D., Scheppach, W., Melcher, R. et al., The Ussing type chamber model to study the intestinal transport and modulation of specific tight-junction genes using a colonic cell line. Mol. Nutr. Food Res. 2009, 53, 1211-1225.
11. Jung, U. J., Lee, M. K., Park, Y. B., Jeon, S. M. et al., Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J. Pharmacol. Exp. Ther. 2006, 318, 476-483.
12. Balasubashini, M. S., Rukkumani, R., Viswanathan, P., Menon, V. P., Ferulic acid alleviates lipid peroxidation in diabetic rats. Phytother. Res. 2004, 18, 310-314.
13. Baker, R. G., Hayden, M. S., Ghosh, S., NF-kappa B, inflammation, and metabolic disease. Cell Metab. 2011, 13, 11-22.
14. Nagy, K., Redeuil, K., Williamson, G., Rezzi, S. et al., First identification of dimethoxycinnamic acids in human plasma after coffee intake by liquid chromatography-mass spectrometry. J. Chromatogr. A. 2011, 1218, 491-497.
15. Grès, M. C., Julian, B., Bourrié, M., Meunier, V. et al., Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm. Res. 1998, 15, 726-733.
16. Guy, P. A., Renouf, M., Barron, D., Cavin, C. et al., Quantitative analysis of plasma caffeic and ferulic acid equivalents by liquid chromatography tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 3965-3974.
17. n identification of chlorogenic acids. J. Agric. Food Chem. 2003, 51, 2900-2911.
18. Farrell, T., Poquet, L., Dionisi, F., Barron, D. et al., Characterization of hydroxycinnamic acid glucuronide and sulfate conjugates by HPLC-DAD-MS2: enhancing chromatographic quantification and application in Caco-2 cell metabolism. J. Pharm. Biomed. Anal. 2011, 55, 1245-1254.
19. ICH. Validation of analytical procedures: text and methodology Q2 (R1). 2005. ICH. http://www.ema.europa.eu.
20. Bryne, D. The Commission of the European Communities, Commission Decision, 2002, (2002/657/EC). OJ L 221, 17.8.2002, p 8. http://eur-lex.europa.eu.
21. Farrell, T. L., Dew, T. P., Poquet, L., Hanson, P. J. et al., Absorption and metabolism of chlorogenic acids in cultured gastric epithelial monolayers. Drug Metab. Dispos. 2011, 39, 2338-2346.
22. MarvinSketch.5.3.1. 2010. ChemAxon. Available from http://www.chemaxon.com
23. Andreasen, M.F., Kroon, P. A., Williamson, G., Garcia-Conesa, M. T., Esterase activity able to hydrolyze dietary antioxidant hydroxycinnamates is distributed along the intestine of mammals. J. Agric. Food Chem. 2001, 49, 5679-5684.
24. Sun, D., Lennernas, H., Welage, L., Barnett, J. et al., Comparison of human duodenum and Caco-2 gene expression profiles for 12, 000 gene sequences tags and correlation with permeability of 26 drugs. Pharm Res. 2002, 19, 1400-1416.
25. Farrell, T. L., Poquet, L., Dew, T. P., Barber, S. et al., Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study. Drug Metab. Dispos. 2012, 40, 397-406.
26. Smith, D., van de Waterbeemd, H., Walker, D., Pharmacokinetics and Metabolism in Drug Design. Wiley-VCH, Weinheim 2006.
27. Redeuil, K., Smarrito-Menozzi, C., Guy, P., Rezzi, S. et al., Identification of novel circulating coffee metabolites in human plasma by liquid chromatography-mass spectrometry. J. Chromatogr. A. 2011, 1218, 4678-4688.
28. Stalmach, A., Mullen, W., Barron, D., Uchida, K. et al., Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption. Drug Metab. Dispos. 2009, 37, 1749-1758.
29. Renouf, M., Guy, P. A., Marmet, C., Fraering, A. L. et al., Measurement of caffeic and ferulic acid equivalents in plasma after coffee consumption: small intestine and colon are key sites for coffee metabolism. Mol. Nutr. Food Res. 2010, 54, 760-766.
30. Poquet, L., Clifford, M. N., Williamson, G., Transport and metabolism of ferulic acid through the colonic epithelium. Drug Metab. Dispos. 2008, 36, 190-197.